Use of recombinant human bone morphogenetic protein for revision cervical spine fusion in children with Down syndrome: a case series

View More View Less
  • 1 Departments of Orthopaedic Surgery and
  • 2 Neurosurgery, Harvard Medical School/Boston Children’s Hospital, Boston, Massachusetts
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

Patients with trisomy 21 (Down syndrome; DS) often have atlantoaxial instability (AAI), which, if severe, causes myelopathy and neurological deterioration. Children with DS and AAI who undergo cervical spine fusion have a high rate of nonunion requiring revision surgery. Recombinant human bone morphogenetic protein–2 (rhBMP-2) is a TGF-β growth factor that is used to induce bone formation in spine fusion. Although previous studies in the adult population have reported no reduction in pseudarthrosis rates with the use of rhBMP-2, there is a lack of literature in the pediatric DS population. This study describes the use of rhBMP-2 in children with DS and AAI during revision to treat nonunion.

METHODS

A retrospective review of a cervical spine fusion database (n = 175) was conducted. This database included all cervical spine fusions using modern instrumentation at the authors’ institution from 2002 to 2019. Patients with DS who underwent a revision utilizing rhBMP-2 were included in the study. The number of prior fusions, use of rhBMP-2 in fusions, length of stay, halo use, and surgical data were collected. Postoperative complications and length of follow-up were also recorded.

RESULTS

Eight patients (75% female) met the inclusion criteria. The average age at revision with rhBMP-2 was 11 years (range 3–19 years). All patients were diagnosed with nonunion after an initial cervical fusion. All revisions were posterior fusions of C1–2 (n = 2) or occiput to cervical (n = 6). All revisions included implant revisions, iliac crest bone grafting, and rhBMP-2 use. One patient required irrigation and debridement of an rhBMP-induced seroma. Another patient required return to the operating room to repair a dural tear. There were no neurological, infectious, airway, or implant-related complications. Revision utilizing rhBMP-2 achieved fusion in 100% (n = 8) of patients. The average length of follow-up was 42.6 months. All patients demonstrated solid fusion mass on the last radiograph.

CONCLUSIONS

This is the first case series reporting the successful use of rhBMP-2 to facilitate cervical spine fusion in patients with DS after previous nonunion. In addition, few rhBMP-2–related postoperative complications occurred.

ABBREVIATIONS AAI = atlantoaxial instability; DS = Down syndrome; rhBMP-2 = recombinant human bone morphogenetic protein–2.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Daniel J. Hedequist: Boston Children’s Hospital, Boston, MA. daniel.hedequist@childrens.harvard.edu.

INCLUDE WHEN CITING Published online January 31, 2020; DOI: 10.3171/2019.11.PEDS19622.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

  • 1

    Alt V, Borgman B, Eicher A, Heiss C, Kanakaris NK, Giannoudis PV, : Effects of recombinant human bone morphogenetic protein-2 (rhBMP-2) in grade III open tibia fractures treated with unreamed nails—a clinical and health-economic analysis. Injury 46:22672272, 2015

    • Search Google Scholar
    • Export Citation
  • 2

    Alvarez N, Rubin L: Atlantoaxial instability in adults with Down syndrome: a clinical and radiological survey. Appl Res Ment Retard 7:6778, 1986

    • Search Google Scholar
    • Export Citation
  • 3

    Barcak EA, Beebe MJ: Bone morphogenetic protein: is there still a role in orthopedic trauma in 2017? Orthop Clin North Am 48:301309, 2017

    • Search Google Scholar
    • Export Citation
  • 4

    Bertolizio G, Saint-Martin C, Ingelmo P: Cervical instability in patients with trisomy 21: the eternal gamble. Paediatr Anaesth 28:830833, 2018

    • Search Google Scholar
    • Export Citation
  • 5

    Brockmeyer D: Down syndrome and craniovertebral instability. Topic review and treatment recommendations. Pediatr Neurosurg 31:7177, 1999

    • Search Google Scholar
    • Export Citation
  • 6

    Brockmeyer DL, Sivakumar W, Mazur MD, Sayama CM, Goldstein HE, Lew SM, : Identifying factors predictive of atlantoaxial fusion failure in pediatric patients: lessons learned from a retrospective pediatric craniocervical society study. Spine (Phila Pa 1976) 43:754760, 2018

    • Search Google Scholar
    • Export Citation
  • 7

    Bull MJ: Health supervision for children with Down syndrome. Pediatrics 128:393406, 2011

  • 8

    Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 22:233241, 2004

  • 9

    Davidson RG: Atlantoaxial instability in individuals with Down syndrome: a fresh look at the evidence. Pediatrics 81:857865, 1988

  • 10

    Dedlow ER, Siddiqi S, Fillipps DJ, Kelly MN, Nackashi JA, Tuli SY: Symptomatic atlantoaxial instability in an adolescent with trisomy 21 (Down’s syndrome). Clin Pediatr (Phila) 52:633638, 2013

    • Search Google Scholar
    • Export Citation
  • 11

    Doyle JS, Lauerman WC, Wood KB, Krause DR: Complications and long-term outcome of upper cervical spine arthrodesis in patients with Down syndrome. Spine (Phila Pa 1976) 21:12231231, 1996

    • Search Google Scholar
    • Export Citation
  • 12

    Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, : Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84:21232134, 2002

    • Search Google Scholar
    • Export Citation
  • 13

    Guppy KH, Harris J, Chen J, Paxton EW, Alvarez J, Bernbeck J: Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients. J Neurosurg Spine 24:556564, 2016

    • Search Google Scholar
    • Export Citation
  • 14

    Guppy KH, Paxton EW, Harris J, Alvarez J, Bernbeck J: Does bone morphogenetic protein change the operative nonunion rates in spine fusions? Spine (Phila Pa 1976) 39:18311839, 2014

    • Search Google Scholar
    • Export Citation
  • 15

    Herford AS: The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma. Chin J Traumatol 20:13, 2017

    • Search Google Scholar
    • Export Citation
  • 16

    Hissnauer TN, Stiel N, Babin K, Rupprecht M, Ridderbusch K, Rueger JM, : Recombinant human bone morphogenetic protein-2 (rhBMP-2) for the treatment of nonunion of the femur in children and adolescents: a retrospective analysis. BioMed Res Int 2017:3046842, 2017

    • Search Google Scholar
    • Export Citation
  • 17

    Hofler RC, Pecoraro N, Jones GA: Outcomes of surgical correction of atlantoaxial instability in patients with Down syndrome: systematic review and meta-analysis. World Neurosurg 126:e125e135, 2019

    • Search Google Scholar
    • Export Citation
  • 18

    Jain A, Hassanzadeh H, Strike SA, Skolasky RL, Riley LH III: rhBMP use in cervical spine surgery: associated factors and in-hospital complications. J Bone Joint Surg Am 96:617623, 2014

    • Search Google Scholar
    • Export Citation
  • 19

    Lerman JA, Emans JB, Hall JE, Karlin LI: Spinal arthrodesis for scoliosis in Down syndrome. J Pediatr Orthop 23:159161, 2003

  • 20

    Lu DC, Sun PP: Bone morphogenetic protein for salvage fusion in an infant with Down syndrome and craniovertebral instability. Case report. J Neurosurg 106 (6 Suppl):480483, 2007

    • Search Google Scholar
    • Export Citation
  • 21

    Matsuda Y, Sano N, Watanabe S, Oki S, Shibata T: Atlanto-occipital hypermobility in subjects with Down’s syndrome. Spine (Phila Pa 1976) 20:22832286, 1995

    • Search Google Scholar
    • Export Citation
  • 22

    McKay SD, Al-Omari A, Tomlinson LA, Dormans JP: Review of cervical spine anomalies in genetic syndromes. Spine (Phila Pa 1976) 37:E269E277, 2012

    • Search Google Scholar
    • Export Citation
  • 23

    Milbrandt TA, Johnston CE 2nd: Down syndrome and scoliosis: a review of a 50-year experience at one institution. Spine (Phila Pa 1976) 30:20512055, 2005

    • Search Google Scholar
    • Export Citation
  • 24

    Mladenov KV, Kunkel P, Stuecker R: The use of recombinant human BMP-2 as a salvage procedure in the pediatric spine: a report on 3 cases. Eur Spine J 19 (Suppl 2):S135S139, 2010

    • Search Google Scholar
    • Export Citation
  • 25

    Molinari RW, Molinari C: The use of bone morphogenetic protein in pediatric cervical spine fusion surgery: case reports and review of the literature. Global Spine J 6:e41e46, 2016

    • Search Google Scholar
    • Export Citation
  • 26

    Pueschel SM: Atlanto-axial subluxation in Down syndrome. Lancet 1:980, 1983 (Letter)

  • 27

    Pueschel SM: Should children with Down syndrome be screened for atlantoaxial instability? Arch Pediatr Adolesc Med 152:123125, 1998

  • 28

    Pueschel SM, Scola FH: Atlantoaxial instability in individuals with Down syndrome: epidemiologic, radiographic, and clinical studies. Pediatrics 80:555560, 1987

    • Search Google Scholar
    • Export Citation
  • 29

    Rocque BG, Kelly MP, Miller JH, Li Y, Anderson PA: Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature. J Neurosurg Pediatr 14:635643, 2014

    • Search Google Scholar
    • Export Citation
  • 30

    Sayama C, Hadley C, Monaco GN, Sen A, Brayton A, Briceño V, : The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months’ follow-up with computed tomography. J Neurosurg Pediatr 16:1420, 2015

    • Search Google Scholar
    • Export Citation
  • 31

    Segal LS, Drummond DS, Zanotti RM, Ecker ML, Mubarak SJ: Complications of posterior arthrodesis of the cervical spine in patients who have Down syndrome. J Bone Joint Surg Am 73:15471554, 1991

    • Search Google Scholar
    • Export Citation
  • 32

    Semine AA, Ertel AN, Goldberg MJ, Bull MJ: Cervical-spine instability in children with Down syndrome (trisomy 21). J Bone Joint Surg Am 60:649652, 1978

    • Search Google Scholar
    • Export Citation
  • 33

    Siemionow K, Hansdorfer M, Janusz P, Mardjetko S: Complications in adult patients with Down syndrome undergoing cervical spine surgery using current instrumentation techniques and rhBMP-2: a long-term follow-up. J Neurol Surg A Cent Eur Neurosurg 78:113123, 2017

    • Search Google Scholar
    • Export Citation
  • 34

    Singh K, Ahmadinia K, Park DK, Nandyala SV, Marquez-Lara A, Patel AA, : Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature. Spine (Phila Pa 1976) 39:91101, 2014

    • Search Google Scholar
    • Export Citation
  • 35

    Tannoury CA, An HS: Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Spine J 14:552559, 2014

Metrics

All Time Past Year Past 30 Days
Abstract Views 52 52 52
Full Text Views 12 12 12
PDF Downloads 16 16 16
EPUB Downloads 0 0 0